BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantLoading investors…
Activity from announced rounds
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Developing best-in-class radiopharmaceuticals for cancer treatment
Develops lead-212 targeted alpha therapies to treat cancer
Pitching Catalio Capital Management? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room